Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% – Ars Technica
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% Ars TechnicaModerna’s Stock Plummets After Cancer-Vaccine Data Shared on Social Media WSJCancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report The New York TimesA novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning AP NewsModerna stock crashes as leaked melanoma data threatens its record August rally Yahoo Finance
সূত্র: মূল সংবাদসূত্র
